Literature DB >> 16682666

Predictors of hemorrhage in patients with untreated brain arteriovenous malformation.

C Stapf1, H Mast, R R Sciacca, J H Choi, A V Khaw, E S Connolly, J Pile-Spellman, J P Mohr.   

Abstract

BACKGROUND: Intracranial hemorrhage is a serious possible complication in patients with brain arteriovenous malformation (AVM). Several morphologic factors associated with hemorrhagic AVM presentation have been established, but their relevance for the risk of subsequent AVM hemorrhage remains unclear.
METHODS: The authors analyzed follow-up data on 622 consecutive patients from the prospective Columbia AVM database, limited to the period between initial AVM diagnosis and the start of treatment (i.e., any endovascular, surgical, or radiation therapy). Univariate and multivariate logistic regression and Cox proportional hazard models were applied to analyze the effect of patient age, gender, AVM size, anatomic location, venous drainage pattern, and associated arterial aneurysms on the risk of intracranial hemorrhage at initial presentation and during follow-up.
RESULTS: The mean pretreatment follow-up was 829 days (median: 102 days), during which 39 (6%) patients experienced AVM hemorrhage. Increasing age (hazard ratio [HR] 1.05, 95% CI 1.03 to 1.08), initial hemorrhagic AVM presentation (HR 5.38, 95% CI 2.64 to 10.96), deep brain location (HR 3.25, 95% CI 1.30 to 8.16), and exclusive deep venous drainage (HR 3.25, 95% CI 1.01 to 5.67) were independent predictors of subsequent hemorrhage. Annual hemorrhage rates on follow-up ranged from 0.9% for patients without hemorrhagic AVM presentation, deep AVM location, or deep venous drainage to as high as 34.4% for those harboring all three risk factors.
CONCLUSIONS: Hemorrhagic arteriovenous malformation (AVM) presentation, increasing age, deep brain location, and exclusive deep venous drainage appear to be independent predictors for AVM hemorrhage during natural history follow-up. The risk of spontaneous hemorrhage may be low in AVMs without these risk factors.

Entities:  

Mesh:

Year:  2006        PMID: 16682666     DOI: 10.1212/01.wnl.0000210524.68507.87

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  132 in total

1.  Angioarchitecture of brain arteriovenous malformations and the risk of bleeding: an analysis of patients in northeastern malaysia.

Authors:  Shibani Kandai; Mohd Shafie Abdullah; Nyi Nyi Naing
Journal:  Malays J Med Sci       Date:  2010-01

2.  Operative classification of brain arteriovenous malformations.

Authors:  A Beltramello; P Zampieri; G K Ricciardi; A Pasqualin; A Nicolato; F Sala; E Piovan; M Gerosa
Journal:  Interv Neuroradiol       Date:  2008-05-12       Impact factor: 1.610

3.  Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture.

Authors:  Yi Guo; Tara Saunders; Hua Su; Helen Kim; Deniz Akkoc; David A Saloner; Steven W Hetts; Christopher Hess; Michael T Lawton; Andrew W Bollen; Tony Pourmohamad; Charles E McCulloch; Tarik Tihan; William L Young
Journal:  Stroke       Date:  2012-02-02       Impact factor: 7.914

4.  Endovascular treatment accounts for a change in brain arteriovenous malformation natural history risk.

Authors:  X Lv; Z Wu; C Jiang; Y Li; X Yang; Y Zhang; M Lv; N Zhang
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

5.  Risk factors of intracranial hemorrhage after brain AVM interventional therapy and its effects on prognosis.

Authors:  Guobin Li; Kun Han; Haiying Yang; Hui Huang; Hong Yang; Dezhang Zhu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  Spontaneous Thrombosis of a Ruptured Brain Arteriovenous Malformation: The Argument for Early Conservative Management.

Authors:  Nitin Goyal; Daniel Hoit; Lucas Elijovich
Journal:  Interv Neurol       Date:  2015-07

7.  Bleeding source identification and treatment in brain arteriovenous malformations.

Authors:  N Mjoli; D Le Feuvre; A Taylor
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

8.  Association of tumor necrosis factor-alpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment.

Authors:  Achal S Achrol; Helen Kim; Ludmila Pawlikowska; K Y Trudy Poon; Charles E McCulloch; Nerissa U Ko; S Claiborne Johnston; Michael W McDermott; Jonathan G Zaroff; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2007-10       Impact factor: 4.654

9.  Assessment and treatment of stroke in children.

Authors:  Lori C Jordan
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

10.  The rationale behind "A Randomized Trial of Unruptured Brain AVMs" (ARUBA).

Authors:  Christian Stapf
Journal:  Acta Neurochir Suppl       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.